These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24021350)

  • 1. Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4).
    Wang C; Lin W; Playa H; Sun S; Cameron K; Buolamwini JK
    Biochem Pharmacol; 2013 Dec; 86(11):1531-40. PubMed ID: 24021350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
    Ward JL; Sherali A; Mo ZP; Tse CM
    J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
    Endo Y; Obata T; Murata D; Ito M; Sakamoto K; Fukushima M; Yamasaki Y; Yamada Y; Natsume N; Sasaki T
    Cancer Sci; 2007 Oct; 98(10):1633-7. PubMed ID: 17711502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH.
    Tandio D; Vilas G; Hammond JR
    Sci Rep; 2019 Sep; 9(1):13555. PubMed ID: 31537831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors.
    Lin W; Buolamwini JK
    J Med Chem; 2007 Aug; 50(16):3906-20. PubMed ID: 17636949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
    Bone DB; Hammond JR
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of 2-diethanolamino-4,8-diheptamethyleneimino-2-(N-aminoethyl-N-ethanolamino)-6-(N,N-diethanolamino)pyrimido[5,4-d]pyrimidine-fluorescein conjugate (8MDP-fluor), as a novel equilibrative nucleoside transporter probe.
    Lin W; Buolamwini JK
    Bioconjug Chem; 2011 Jun; 22(6):1221-7. PubMed ID: 21539390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria parasite type 4 equilibrative nucleoside transporters (ENT4) are purine transporters with distinct substrate specificity.
    Frame IJ; Merino EF; Schramm VL; Cassera MB; Akabas MH
    Biochem J; 2012 Sep; 446(2):179-90. PubMed ID: 22670848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins.
    Young JD; Yao SY; Sun L; Cass CE; Baldwin SA
    Xenobiotica; 2008 Jul; 38(7-8):995-1021. PubMed ID: 18668437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
    Visser F; Vickers MF; Ng AM; Baldwin SA; Young JD; Cass CE
    J Biol Chem; 2002 Jan; 277(1):395-401. PubMed ID: 11689555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Progress on Equilibrative Nucleoside Transporter Function and Inhibitor Design.
    Rehan S; Shahid S; Salminen TA; Jaakola VP; Paavilainen VO
    SLAS Discov; 2019 Dec; 24(10):953-968. PubMed ID: 31503511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).
    Playa H; Lewis TA; Ting A; Suh BC; Muñoz B; Matuza R; Passer BJ; Schreiber SL; Buolamwini JK
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5801-5804. PubMed ID: 25454272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
    Visser F; Zhang J; Raborn RT; Baldwin SA; Young JD; Cass CE
    Mol Pharmacol; 2005 Apr; 67(4):1291-8. PubMed ID: 15644498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters.
    Visser F; Baldwin SA; Isaac RE; Young JD; Cass CE
    J Biol Chem; 2005 Mar; 280(12):11025-34. PubMed ID: 15649894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of benzopyranone derivatives and related compounds with human concentrative nucleoside transporters 1, 2 and 3 heterologously expressed in porcine PK15 nucleoside transporter deficient cells. Structure-activity relationships and determinants of transporter affinity and selectivity.
    Wang C; Pimple S; Buolamwini JK
    Biochem Pharmacol; 2010 Feb; 79(3):307-20. PubMed ID: 19735647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
    Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
    Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
    Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.